2011
DOI: 10.1002/rcm.4984
|View full text |Cite
|
Sign up to set email alerts
|

Ultrafast mass spectrometry based bioanalytical method for digoxin supporting an in vitro P‐glycoprotein (P‐gp) inhibition screen

Abstract: The evaluation of interactions between drug candidates and transporters such as P-glycoprotein (P-gp) has gained considerable interest in drug discovery and development. Inhibition of P-gp can be assessed by performing bi-directional permeability studies with in vitro P-gp-expressing cellular model systems such as Caco-2 (human colon carcinoma) cells, using digoxin as a substrate probe. Existing methodologies include either assaying (3)H-digoxin with liquid scintillation counting (LSC) detection or assaying no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
12
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
4

Relationship

2
8

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 28 publications
1
12
0
Order By: Relevance
“…The developed system and methods using multiplexed LC coupled with MIC data acquisition significantly reduced the injection‐to‐injection cycle time (23 s) than our previously reported platform. This cycle time approaches those reported for the new ADDA system and RapidFire system, with both running direct online SPE in MIC mode. In comparison, advantages of this platform reported herein include its relatively lower cost, its compatibility with various LC and MS components from major vendors, and its single point software control by Aria.…”
Section: Resultssupporting
confidence: 71%
“…The developed system and methods using multiplexed LC coupled with MIC data acquisition significantly reduced the injection‐to‐injection cycle time (23 s) than our previously reported platform. This cycle time approaches those reported for the new ADDA system and RapidFire system, with both running direct online SPE in MIC mode. In comparison, advantages of this platform reported herein include its relatively lower cost, its compatibility with various LC and MS components from major vendors, and its single point software control by Aria.…”
Section: Resultssupporting
confidence: 71%
“…13 The RapidFire system is a fully automated front-end platform that couples high-speed online SPE with MS-based detection, and has been successfully used to support various in vitro high-throughput screening and liability assessment assays, which have been described previously. [14][15][16] By combining an ultrafast microfluidic robotic system with custom micro-SPE cartridges, the RapidFire is capable of quickly desalting samples prior to their introduction into the mass spectrometer and is compatible with existing sample extraction procedures. However, sample volume requirements (~40-50 µL) prevent further miniaturization of existing protocols to accommodate increasing throughput demands (as is typical in a lead discovery/HTS environment), and at 10 s/sample, it is not comparable to the analysis speeds of fluorescence-based plate readers.…”
Section: Introductionmentioning
confidence: 99%
“…The absence of a chromatographic separation allows for a significant decrease in cycle time per sample compared with traditional LC-MS/MS (e.g., 8-20 s compared with 3-5 min, respectively). RF-MS/MS and similar systems have proven to be successful with in vitro ADME assays, [3][4][5][6][7][8][9][10] but to our knowledge, there have been no peer-reviewed published reports on the application of RF-MS/MS for PPB analysis. This article explores the application of a fully integrated RF-MS/MS system to increase sample throughput, decrease the time burden on existing laboratory instrumentation, and improve turnaround time for PPB results.…”
Section: Introductionmentioning
confidence: 99%